These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1152 related articles for article (PubMed ID: 33988162)

  • 1. Cardiovascular impact of COVID-19: an array of presentations.
    Maab H; Mustafa F; Shabbir SJ
    Acta Biomed; 2021 May; 92(2):e2021021. PubMed ID: 33988162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular complications in COVID-19.
    Long B; Brady WJ; Koyfman A; Gottlieb M
    Am J Emerg Med; 2020 Jul; 38(7):1504-1507. PubMed ID: 32317203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Involvement of COVID-19: A Comprehensive Review.
    Chang WT; Toh HS; Liao CT; Yu WL
    Am J Med Sci; 2021 Jan; 361(1):14-22. PubMed ID: 33187633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular aspects of COVID-19.
    Kurz DJ; Eberli FR
    Swiss Med Wkly; 2020 Dec; 150():w20417. PubMed ID: 33382450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports.
    Soumya RS; Unni TG; Raghu KG
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):411-425. PubMed ID: 32926272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial injury and COVID-19: Possible mechanisms.
    Babapoor-Farrokhran S; Gill D; Walker J; Rasekhi RT; Bozorgnia B; Amanullah A
    Life Sci; 2020 Jul; 253():117723. PubMed ID: 32360126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
    Abdel Moneim A; Radwan MA; Yousef AI
    Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Manifestations of COVID-19 Infection.
    Magadum A; Kishore R
    Cells; 2020 Nov; 9(11):. PubMed ID: 33228225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 and the cardiovascular system.
    Hafiane A
    Clin Chim Acta; 2020 Nov; 510():311-316. PubMed ID: 32681935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
    Rochette L; Ghibu S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Complications in Coronavirus Disease 2019-Pathogenesis and Management.
    Restrepo MI; Marin-Corral J; Rodriguez JJ; Restrepo V; Cavallazzi R
    Semin Respir Crit Care Med; 2023 Feb; 44(1):21-34. PubMed ID: 36646083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2.
    Lawal IO; Kgatle MM; Mokoala K; Farate A; Sathekge MM
    BMC Cardiovasc Disord; 2022 Mar; 22(1):93. PubMed ID: 35264107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
    Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
    Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
    Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.
    Luo J; Zhu X; Jian J; Chen X; Yin K
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):273-282. PubMed ID: 33428706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
    Hendren NS; Drazner MH; Bozkurt B; Cooper LT
    Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease 2019 and cardiovascular system: A narrative review.
    Kwenandar F; Japar KV; Damay V; Hariyanto TI; Tanaka M; Lugito NPH; Kurniawan A
    Int J Cardiol Heart Vasc; 2020 Aug; 29():100557. PubMed ID: 32550259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
    Wu L; O'Kane AM; Peng H; Bi Y; Motriuk-Smith D; Ren J
    Biochem Pharmacol; 2020 Aug; 178():114114. PubMed ID: 32579957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and cardiovascular diseases.
    Liu F; Liu F; Wang L
    J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.